Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent Technologies, a leading tools provider in ...
The agreement involves the integration of Tagomics' Interlace epigenetic profiling platform with Agilent's SureSelect library preparation and target enrichment products.
Cambridge-based Tagomics Ltd., a biomarker discovery and diagnostics company, has entered into a strategic co-marketing ...
The agreement offers select customers the opportunity to access Tagomics’ and Agilent Technologies’ combined innovative offerings through an exclusive technology access program hosted out of ...
CAMBRIDGE, England--(BUSINESS WIRE)--Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement with Agilent ...
CAMBRIDGE, England, November 20, 2024--(BUSINESS WIRE)--Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has entered into a strategic co-marketing agreement ...